What we're reading, January 2, 2017: drug makers are taking a cautious approach to off-label promotion; Republicans eye changes to Medicaid under Trump administration; and the impact of geography on health.
Almost a year ago, a court ruling may have opened the gate for drug makers to promote off-label uses for medications, but most companies are playing it safe, for now. According to MedPage Today, companies are taking a “wait-and-see” approach and avoiding and promotion of off-label uses that would put them into dispute with the FDA. Traditionally, the FDA has a zero-tolerance policy for off-label promotion, but the court ruling means the agency can’t outright ban the this type of communication.
Republicans are planning a lot of changes for healthcare under the Trump administration. In addition to repealing and replacing the Affordable Care Act and weighing a possible privatization of veterans’ medical care, the GOP is eyeing an overhaul to Medicaid, reported AP. Trump and Republicans are considering using block grants for the program, which supporters say will rein in spending. Critics are worried about big cuts. Currently, there are 70 million people covered by Medicaid.
Where a person lives can have a big impact on his or her health. A recent report highlighted how much of an impact geography can have with the finding that people in Mississippi live to 75, on average, while people in Hawaii can live longer than 81 years. The Washington Post outlined numerous interventions occurring across the country that are based on geographic data, such as a home inspection program in one Connecticut city based on data that there was a high rate of asthma-related hospitalizations.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More